Moderna says its COVID-19 vaccine safe for children as young as six months old
Daily MailModerna announced Wednesday morning that it has successfully completed clinical trials for its COVID-19 vaccine in children as young as six months old - and it will soon submit data to federal regulators to get the shot approved. Moderna announced Wednesday that it has completed Phase 2 and 3 clinical trials for its COVID-19 vaccine in children aged six months to six years old. Not all experts are convinced that children require the COVID-19 vaccine, since deaths are rare, they are less likely to have a symptomatic case and they may even be less likely to spread the virus Pfizer has also attempted to get its Covid vaccine approved for children in the six months to six year old age group, but has run into issues as the small dosage had minimal effectiveness is older aged children A study from the University of Utah last year found that 50 percent of pediatric Covid cases are asymptomatic. UNDER FIVES SUFFER LITTLE RISK FROM COVID-19 Children face little risk from COVID-19 when infected, data from multiple studies and sources shows The CDC reports that children only account less than 0.1 percent of Covid deaths in the U.S. since the pandemic first began Pfizer's vaccine trials for children under the age of five was hampered by the extremely low number of children from the control group who were hospitalized with the virus A study from the University of Utah last year found that 50 percent of pediatric Covid cases are asymptomatic.